EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps

Daniel Xiao iD, Martin J Citardi, William C Yao iD, Amber U Luong iD

International Forum of Allergy & Rhinology · 2026

DOI: 10.1002/alr.70121 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Daniel Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School of The University of Texas Health Science Center at Houston, Houston…. Hauptthemen laut MEDLINE: Rhinosinusitis, Fluticasone, Nasal Polyps, Budesonide. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU). This study evaluates the cost‐effectiveness of EDS‐FLU compared to SNI for CRSwNP.

Methods

A cohort‐style Markov decision‐tree economic model with a 33‐year time horizon was developed in TreeAgePro. Because EDS‐FLU is not currently covered by Medicare, costs of medications were estimated using retail pricing. A willingness‐to‐pay threshold of $50,000/quality adjusted life year (QALY) was used to determine cost‐effectiveness. One‐way and probabilistic sensitivity analysis was conducted using 10,000 Monte Carlo simulations.

Results

EDS‐FLU had an incremental benefit of 0.41 QALYs compared to SNI. In base case analysis, EDS‐FLU costs $140,966.63 after the study period, whereas SNI costs $40,817.50. With an ICER of $244,185.37/QALY, SNI is the more cost‐effective strategy. Probabilistic sensitivity analysis reported SNI as the cost‐effective strategy in 98.50% of simulations.

Conclusions

Compared to EDS‐FLU, SNI is the cost‐effective strategy for treating CRSwNP following FESS. Changes in drug pricing and improvements in patient selection may cause adjustments in the most cost‐effective strategy for CRSwNP management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhinosinusitisFluticasoneNasal PolypsBudesonideAnti-Inflammatory AgentsSinusitisRhinitisAndrostadienesHumansChronic DiseaseCost-Benefit AnalysisMarkov ChainsQuality-Adjusted Life YearsCost-Effectiveness AnalysisNasal LavageDrug Delivery SystemsExhalation

Stichwörter der Autor:innen

chronic rhinosinusitishealth care economicsmedical therapy of chronic rhinosinusitis

Substanzen

FluticasoneBudesonideAnti-Inflammatory AgentsAndrostadienes

Autor:innen und Institutionen

  • Department of Otorhinolaryngology-Head and Neck Surgery, McGovern Medical School of The University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Center for Immunology and Autoimmune Diseases, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, McGovern Medical School of The University of Texas Health Science Center at Houst…

ORCID-Profile: Daniel Xiao, William C Yao, Amber U Luong

Zitieren

APA

Xiao, D., Citardi, M. J., Yao, W. C., & Luong, A. U. (2026). Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70121

Vancouver

Xiao D, Citardi MJ, Yao WC, Luong AU. Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70121

BibTeX
@article{Xiao2026,
  author = {Xiao, Daniel and Citardi, Martin J and Yao, William C and Luong, Amber U},
  title = {Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  doi = {10.1002/alr.70121}
}
Kostenlos starten →